German Federal Joint Committee (G-BA)

Germany has clarified the timing of the planned expansion of the §137h early benefit assessment. For the current NUB application period, the procedure will continue to apply only to new inpatient methods involving high-risk medical devices. Once the amended G-BA Rules of Procedure take effect, expected from the next application cycle, the assessment will broaden to new methods based on a new theoretical scientific concept and will no longer be limited to high-risk devices.

On September 1, 2025, the Institute for Hospital Remuneration Systems (INeK) announced the start of the application process according to §6 (2) KHEntgG (New Examination and Treatment Methods, NUB) for 2026.

On June 20, 2025, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for healthcare research projects (seven topics) and clinical guidelines (three topics).

In late February 2025, the Innovation Committee at the Federal Joint Committee (G-BA) published the decision recommending the transfer to standard care for the completed project in the peripheral vascular field. The project was dedicated to the integration and spatial analysis of regional, site-specific, and patient-specific factors to improve the quality of care in carotid artery revascularization.

On January 24, 2025, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for projects on new forms of care (for single-stage process – open topic and for two-stage process – nine topics).

In late November 2024, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions recommending the transfer to standard care for two completed projects. The projects were dedicated to relieving the burden of emergency rooms and improving infection surveillance in nursing homes.

In mid-August 2024, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions recommending the transfer to standard care for another four completed projects. The projects were dedicated to the topics of support for families with a parent suffering from cancer, modeling routine risk screening in children, reducing problematic media use, promoting treatment motivation in people with computer game addiction and Internet addiction, and follow-up care for gestational diabetes.

In late June – mid-July 2024, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions recommending the transfer to standard care for another three completed projects. The projects were dedicated to the topics of care concept for patients with hidradenitis suppurativa (acne inversa), the use of webcams in neonatal intensive care units, and improving the pharmacovigilance of innovative therapies.

On June 21, 2024, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for healthcare research projects (eight topics) and clinical guidelines (three topics).

On May 27, 2024, the Innovation Committee at the Federal Joint Committee (G-BA) announced that ninety-one applications (project ideas) for innovation funding of the projects for new forms of care were received.

On May 17, 2024, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions recommending the transfer to standard care for another three completed projects. The projects were dedicated to the topics of booster vaccination against meningococci of serogroup C, reduction of antibiotic resistance, and dual pilot structure for diagnosis clarification in centers for rare diseases.

On May 17, 2024, the Innovation Committee at the Federal Joint Committee (G-BA) announced that forty-eight applications for innovation funding of healthcare research projects were accepted.